Position Statements

Guidelines

Here you will find our prescribing guidelines including shared care guidelines and patient information leaflets.

To see which CCGs have adopted the guidance please download the document below:

Name	Size	Hits
Biological Agents For Treating JIA In Adult Patients (Version 2.0)	208.7 KiB	771
Biosimilars of Etanercept (Version 1.0)	268.5 KiB	601
Biosimilars of Infliximab (Version 1.1)	271.7 KiB	1714
Cannabis Based Medicinal Products For Pain (Version 1.0)	464.8 KiB	275
Choice of direct-acting oral anticoagulant (DOAC) for stroke prevention in atrial fibrillation (AF) (Version 1.2)	213.3 KiB	555
Denosumab Position Statement (Version 1.0)	291.3 KiB	659
E‑Cigarettes Position Statement (Version 2.0)	162.8 KiB	930
Empagliflozin Position Statement (Version 1.0)	577.8 KiB	1071
Fentanyl & Buprenorphine Patches For Pain (Version 1.0)	332.4 KiB	42302
Generic Biosimilar Position Statement (Version 1.0)	218.0 KiB	723
Melatonin Position Statement (Version 1.2)	615.1 KiB	849
Nutritional Supplements Post Bariatric Surgery (version 1.1)	281.4 KiB	7470
Out Of Area Prescribing Position Statement (Version 1.0)	166.1 KiB	150
PKU (Phlexy-Vit) Position Statement (Version 1.0)	664.8 KiB	384
Trans-Anal Irrigation Devices Position Statement (version 1.2)	230.4 KiB	1622
Vitamin D Position Statement (Version 2.1)	375.9 KiB	3969
Vitamins And Minerals (Version 1.2)	295.0 KiB	1377